Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Heparin - Troikaa Pharmaceuticals

Next Previous
Search
Drug Profile

Heparin - Troikaa Pharmaceuticals

Alternative Names: Heparin QPS - Troikaa; Heparin sodium - Troikaa; Heparin sodium topical solution 1000 IU/ml - Triokaa; Phlebotroy QPS

Latest Information Update: 07 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Troikaa Pharmaceuticals
  • Class Anti-infectives; Anti-inflammatories; Antithrombotics; Bronchodilators; Heparins; Mucolytics
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Thrombosis

Most Recent Events

  • 25 Jun 2018 Troikaa Pharmaceuticals plans a phase II/III trial for Phlebitis in India (CTRI/2018/05/013701)
  • 02 May 2017 Troikaa Pharmaceuticals initiates a phase III trial for Thrombosis (Prevention) in India (CTRI2017-03-008263)
  • 30 Mar 2017 Launched for Thrombosis (Prevention) in India prior to March 2017 (Topical)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top